2-(N-substituted guanidino)-4-hetero-arylthiazole antiulcer agents
AssigneePfizer Inc.
InventorLawrence A. Reiter
Life of this patent
Estimating the term…
Loading patent…
AssigneePfizer Inc.
InventorLawrence A. Reiter
Estimating the term…
2,4-Disubstituted thiazole compounds of the formula ##STR1## or a pharmaceutically acceptable acid addition salt thereof wherein X is NH and Y is CH or N, or X is S and Y is CH; R.sup.1 is certain straight or branched chain alkyl groups, (R.sup.3).sub.2 C.sub.6 H.sub.3, or (R.sup.3).sub.2 Ar(CH.sub.2).sub.n where n is an integer from 1 to 4, R.sup.3 is H or certain substituent groups and Ar is phenylene, naphthalene or the residue of certain heteroaromatic groups; R.sup.2 is H or (C.sub.1 -C.sub.4)alkyl; or R.sup.1 and R.sup.2 taken together with the nitrogen atom to which they are attached form certain heterocyclic groups; and R.sup.4 is H, (C.sub.1 -C.sub.5)alkyl, NH.sub.2 or CH.sub.2 OH; a method for their use in treatment of gastric ulcers in mammals and pharmaceutical compositions containing said compounds.
A compound of the formula ##STR47## or a pharmaceutically acceptable acid addition salt thereof, wherein X is NH and Y is CH or N, or
Dependencies are inferred from the claim text.